Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?

Antioxidants and Redox Signaling

Volumn 16, Issue 2, 2012, Pages 165-169

  Barden, Anne E ^a   Corcoran, Tomas B ^a,b   Mas, Emilie ^a   Durand, Thierry ^c   Galano, Jean Marie ^c   Roberts, L Jackson ^d   Paech, Michael ^a,e   Muchatuta, Neil A ^e   Phillips, Michael ^f   Mori, Trevor A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d VANDERBILT UNIVERSITY   (United States)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ISOFURAN; ISOPROSTANE DERIVATIVE; NEUROPROSTANE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; MATERNAL PLASMA; NEWBORN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; CASE-CONTROL STUDIES; FEMALE; FURANS; HUMANS; LIPID METABOLISM; NEUROPROSTANES; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY;

EID: 81755161465     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4214     Document Type: Article

References (9)

1. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, and Michael CA. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci 91: 711-718, 1996. (Pubitemid 26413825)
2. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, et al. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 38: 803-808, 2001. (Pubitemid 34258674)
3. Corcoran TB, Mas E, Barden AE, Durand T, Galano J-M, Roberts II LJ, Phillips M, Ho KM, and Mori TA. Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal 15: 2663-2667, 2011.
4. Harsem NK, Braekke K, and Staff AC. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia. Eur J Obstet Gynecol Reprod Biol 128: 209-215, 2006. (Pubitemid 44311326)
5. Harsem NK, Braekke K, Torjussen T, Hanssen K, and Staff AC. Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens Preg 27: 374-386, 2008.
6. Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic Res 38: 913-918, 2004. (Pubitemid 39341686)
7. Roberts LJ and Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 128: 173-186, 2004. (Pubitemid 38167386)
8. Stein TP, Scholl TO, Schluter MD, Leskiw MJ, Chen XH, Spur BW, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res 42: 841-848, 2008.
9. Varma S, Janesko KL, Wisniewski SR, Bayir H, Adelson PD, Thomas NJ, et al. F-2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J Neurotrauma 20: 781-786, 2003. (Pubitemid 36993451)